Skip to main content

RAD December 2020 Abstracts - Page 3

#348 - Interventions to Improve Primary Care Provider Management of Atopic Dermatitis: A Systematic Review

Emily A. Croce, MSN, APRN, CPNP-PC, PhD Student; Fabiana Castro Porto Silva Lopes, MD; Maria Anna Leszczynska, MD; Jennifer Ruth, MD; Jonathan I. Silverberg, MD, PhD, MPH

View Abstract
View Poster

#350 - Rapid Itch Improvement in Children With Severe Atopic Dermatitis Treated With Dupilumab: A Phase 3 Subset Analysis

Gil Yosipovitch, Jonathan I. Silverberg, Jashin J. Wu, Zhen Chen, Randy Prescilla, Ana B. Rossi, Dimittri Delevry 

View Abstract
View Poster

#351 - Dupilumab Induces Rapid and Sustained Improvement in Clinical Signs in Children With Severe Atopic Dermatitis

Amy S. Paller, Elaine C. Siegfried, Peter D. Arkwright, Rui Huang, Haixin Zhang, Noah A. Levit, Karli Rosner, Ana B. Rossi 

View Abstract
View Poster

#352 - Dupilumab Treatment Provides Improvements in Signs of Atopic Dermatitis (AD) at Week 100 in Adult Patients With Moderate-to-Severe AD Who Did Not Achieve ≥75% Reduction in Eczema Area and Severity Index at Week 16

April Armstrong, Andrew Blauvelt, Eric L Simpson, Zhen Chen, Marius Ardeleanu, Ana B. Rossi, Paul Tomondy

View Abstract
View Poster

#353 - The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study

Melinda J. Gooderham, MSc, MD, Leon H. Kircik, MD, Matthew Zirwas, MD, Mark Lee, MD, Steven E. Kempers, MD, Zoe D. Draelos, MD, Laura K. Ferris, MD, PhD, Terry M. Jones, MD, Etienne Saint-Cyr Proulx, MD, Robert Bissonnette, MD, Neal Bhatia, MD, Scott T. Guenthner, MD, Robert A. Koppel, MD, Howard Welgus, MD, Charlotte Merritt, MBA, Meg Elias, BSN, Lynn Navale, MS, Robert C. Higham, MPAS, PA-C, Michael Droege, PhD, David R. Berk, MD

View Abstract
View Poster

#355 - Clinical tailoring of baricitinib 2-mg in atopic dermatitis: baseline body surface area and rapid onset of action identifies response at Week 16

Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsay Strowd, Luna Sun, Yuxin Ding, Orin Goldblum, Fabio P. Nunes, Eric L. Simpson 

View Abstract
View Poster

#356 - A Survey of Adults with Atopic Dermatitis Reveals a Need For Better Symptom Control

Shari J. Dermer, PhD, Piyali Chatterjee-Shin, BS, Anjali Mehra, MD; Pan Chen, PhD; Katie S. Lucero, PhD 

View Abstract
View Poster

#357 - Dupilumab Treatment Improves Health-Related Quality of Life in Children Aged ≥6 to <12 Years With Severe Atopic Dermatitis

Alan D. Irvine, Mette Deleuran, Amy Praestgaard, Dimittri Delevry, Ana B. Rossi

View Abstract
View Poster

#358 - Rates of Cardiovascular Events Among Patients With Moderate-to-Severe Atopic Dermatitis: A Retrospective Cohort Study 

Monique M. Hedderson, Fei Xu, Charles P. Quesenberry, Sneha Sridhar, Jamie Geier, Adina R. Lemeshow

View Abstract
View Poster

#359 - Economic Impact of Abrocitinib Monotherapy and Combination Therapy in Patients With Moderate-to-Severe Atopic Dermatitis: Results From JADE MONO-2 and JADE COMPARE

Melinda J. Gooderham, Chia-Yu Chu, Ricardo Rojo, Hernan Valdez, Pinaki Biswas, Michael C. Cameron, Claire Feeney, Gerardo A. Encinas, Kathleen Peeples-Lamirande, Joseph C. Cappelleri, Daniela E. Myers, Marco DiBonaventura 

View Abstract
View Poster

#360 - A Phase 3 Study to Investigate the Efficacy and Safety of Abrocitinib and Dupilumab in Comparison With Placebo in Adults With Moderate-to-Severe Atopic Dermatitis

Diamant Thaçi, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Carle Paul, Rodney Sinclair, Andrew E. Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernan Valdez 

View Abstract
View Poster
Page 1
Page 2
Page 3
Page 4
Page 5